Emerald Health Therapeutics, Inc. (CVE:EMH – Get Free Report) shares dropped 3.8% during trading on Wednesday . The company traded as low as C$0.25 and last traded at C$0.26. Approximately 384,329 shares changed hands during mid-day trading, a decline of 40% from the average daily volume of 644,760 shares. The stock had previously closed at C$0.27.
Emerald Health Therapeutics Trading Down 3.8%
The company has a quick ratio of 2.61, a current ratio of 2.97 and a debt-to-equity ratio of 35.45. The company has a market cap of C$52.28 million and a P/E ratio of -0.37. The business has a 50-day moving average price of C$0.26 and a two-hundred day moving average price of C$0.26.
Emerald Health Therapeutics Company Profile
Emerald Health Therapeutics, Inc, together with its subsidiaries, produces and sells medical cannabis for medical purpose in Canada. The company is also involved in developing natural health products. It offers dried cannabis strains, pre-rolls, and cannabis oil products to its medical patients. The company was formerly known as T-Bird Pharma Inc and changed its name to Emerald Health Therapeutics, Inc in June 2015. Emerald Health Therapeutics, Inc is headquartered in Vancouver, Canada.
Further Reading
- Five stocks we like better than Emerald Health Therapeutics
- 3 Luxury Consumer Brands to Watch in a Beaten-Down Sector
- Jackson’s Record Quarter Powers the Bull Case
- Holiday Shopping Is Almost Here—And Target May Be Ready to Win Big
- AI Panic Hit Tech Stocks—But NVIDIA’s Growth Engine Is Intact
Receive News & Ratings for Emerald Health Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Emerald Health Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
